Reduction in skin microvascular density and changes in vessel morphology in patients treated with sunitinib.
about
Survival of encapsulated islets: More than a membrane storyTyrosine kinase inhibitors induced thyroid dysfunction: a review of its incidence, pathophysiology, clinical relevance, and treatmentThe outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study.Influence of Tyrosine Kinase Inhibitors on Hypertension and Nephrotoxicity in Metastatic Renal Cell Cancer PatientsManagement of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors.Targeted therapies in renal cell cancer: recent developments in imagingPolymorphisms in endothelial nitric oxide synthase (eNOS) and vascular endothelial growth factor (VEGF) predict sunitinib-induced hypertension.Hypertension as a biomarker of efficacy in patients with metastatic renal cell carcinoma treated with sunitinib.Influence of Adjuvant Therapy in Cancer Survivors on Endothelial Function and Skeletal Muscle Deoxygenation.Treatment of sunitinib-induced hypertension in solid tumor by nitric oxide donors.Vascular Toxicities of Cancer Therapies: The Old and the New--An Evolving Avenue.The risk of hand foot skin reaction to pazopanib, a novel multikinase inhibitor: a systematic review of literature and meta-analysis.Toxicity as a biomarker of efficacy of molecular targeted therapies: focus on EGFR and VEGF inhibiting anticancer drugs.Targeting the epidermal growth factor receptor in solid tumors: focus on safety.A phase 2 study of the efficacy and biomarker on the combination of transarterial chemoembolization and axitinib in the treatment of inoperable hepatocellular carcinoma.Recent Advances in Hypertension and Cardiovascular Toxicities With Vascular Endothelial Growth Factor Inhibition.An exploratory association of polymorphisms in angiogenesis-related genes with susceptibility, clinical response and toxicity in gastrointestinal stromal tumors receiving sunitinib after imatinib failure.Early Actions of Anti-Vascular Endothelial Growth Factor/Vascular Endothelial Growth Factor Receptor Drugs on Angiogenic Blood Vessels.Capillary rarefaction in advanced chronic kidney disease is associated with high phosphorus and bicarbonate levels.Capillary rarefaction from the kidney point of view.
P2860
Q26751467-CC06D00F-4DD8-46B3-A1E2-FF2F4D241ECDQ26998914-41742261-98DF-4075-A546-3DDBFE1B12B4Q27851744-C6BCAC17-EDB7-433F-9677-3C9627826C80Q28080163-E86C0B02-3A10-46BB-A59F-24E2D81408EAQ30417015-346A2C29-955C-4FA1-B1DA-558ECDC01678Q34088696-7FB4A47B-60FC-4673-B387-6899F75DF518Q34403301-8357E1B5-E988-4E17-8948-292B07CEDC67Q34916352-328FAEA3-B0D6-4F31-8E1B-FE4EBC986541Q35903018-EE995606-3DBF-426B-9BFD-E2BDC75B9087Q36106439-0998B628-6181-4DFB-A58F-9D0DE1F105DDQ36755620-F98524AB-DE87-481F-8F8D-33350D52BC6BQ37851857-C8F8226C-C8BF-48C4-B3E3-BF28F419BC06Q37963823-58D194C8-83CA-412E-B1DC-D990ED2E6FBFQ38200654-417BF8AB-4131-4859-ACEF-E437A40E7E79Q38375159-2032EC73-893E-4D8A-B0D2-862908877BA7Q39384416-2EC8AC89-0672-4244-8234-70429753DABBQ40452107-83A8E232-CDB2-42B5-9FCC-C3BD7946B172Q41954266-03706B5B-5F5A-48BA-9823-A2AFE6F03255Q51490903-9C6228E1-CEBC-48F2-B4EF-3BDFF2CE10ACQ55483555-39AA0312-5E1E-4C09-A364-731693A8FACF
P2860
Reduction in skin microvascular density and changes in vessel morphology in patients treated with sunitinib.
description
2010 nî lūn-bûn
@nan
2010 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Reduction in skin microvascula ...... tients treated with sunitinib.
@ast
Reduction in skin microvascula ...... tients treated with sunitinib.
@en
Reduction in skin microvascula ...... tients treated with sunitinib.
@nl
type
label
Reduction in skin microvascula ...... tients treated with sunitinib.
@ast
Reduction in skin microvascula ...... tients treated with sunitinib.
@en
Reduction in skin microvascula ...... tients treated with sunitinib.
@nl
prefLabel
Reduction in skin microvascula ...... tients treated with sunitinib.
@ast
Reduction in skin microvascula ...... tients treated with sunitinib.
@en
Reduction in skin microvascula ...... tients treated with sunitinib.
@nl
P2093
P1433
P1476
Reduction in skin microvascula ...... tients treated with sunitinib.
@en
P2093
Alfons J M van den Eertwegh
Astrid A M van der Veldt
Epie Boven
Erik H Serné
Michiel P de Boer
Victor W van Hinsbergh
Yvo M Smulders
P304
P356
10.1097/CAD.0B013E3283359C79
P577
2010-04-01T00:00:00Z